Filter your results
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective studyHaematologica, 2015, 100 (12), pp.1579-1586. ⟨10.3324/haematol.2015.133025⟩
Journal articles
inserm-02913989v1
|
||
|
⁹⁰Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation studyThe Lancet, 2015, 2 (3), pp.e108-17. ⟨10.1016/S2352-3026(15)00020-4⟩
Journal articles
inserm-02913620v1
|
||
|
Low non-relapse mortality and long-term preserved quality of life in older patients undergoing matched related donor allogeneic stem cell transplantation: a prospective multicenter phase II trialHaematologica, 2015, 100 (2), pp.269-274. ⟨10.3324/haematol.2014.113571⟩
Journal articles
hal-02167058v1
|